Naloxegol oxalateProduct ingredient for Naloxegol

Name
Naloxegol oxalate
Drug Entry
Naloxegol

Naloxegol, for "PEGylated naloxol" is a peripherally-selective opioid antagonist developed by AstraZeneca. It was approved by the FDA in September 2014 and is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non‑cancer pain. The advantage of naloxegol over the opioid antagonist naloxone is that its PEGylated structure allows for high selectivity for peripheral opioid receptors and lack of entry into the central nervous system through the blood-brain barrier.

Accession Number
DBSALT001245
Structure
Synonyms
Not Available
UNII
65I14TNM33
CAS Number
1354744-91-4
Weight
Average: 741.828
Monoisotopic: 741.357170075
Chemical Formula
C36H55NO15
InChI Key
MNYIRXLCPODKLG-VUTNLTPYSA-N
InChI
InChI=1S/C34H53NO11.C2H2O4/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2;3-1(4)2(5)6/h3-5,28-29,32,36-37H,1,6-25H2,2H3;(H,3,4)(H,5,6)/t28-,29+,32-,33-,34+;/m0./s1
IUPAC Name
(1S,5R,13R,14S,17S)-14-(2,5,8,11,14,17,20-heptaoxadocosan-22-yloxy)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,17-diol; oxalic acid
SMILES
OC(=O)C(O)=O.COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5
ChemSpider
28651655
ChEMBL
CHEMBL2219416
Wikipedia
Naloxegol
Predicted Properties
PropertyValueSource
Water Solubility0.0566 mg/mLALOGPS
logP1.73ALOGPS
logP1.36Chemaxon
logS-4.1ALOGPS
pKa (Strongest Acidic)10.14Chemaxon
pKa (Strongest Basic)8.54Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count12Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area126.77 Å2Chemaxon
Rotatable Bond Count25Chemaxon
Refractivity171.68 m3·mol-1Chemaxon
Polarizability72.87 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon